European shares led higher by tech, banks as US slowdown fears ease
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
Adyen tops profit forecast, shares jump
Admiral surges on forecast-beating profit, special dividend
Orsted books new impairment losses, shares drop
Geberit falls after forecasting flat 2024 sales
STOXX 600 up 1.2%
Updated at 1600 GMT
By Ankika Biswas and Pranav Kashyap
Aug 15 (Reuters) -Technology and bank shares led Europe's benchmark stock index more than 1% higher on Thursday, with risk appetite boosted by strong U.S. retail sales data that eased fears of a slowdown in the world's largest economy.
The pan-European STOXX 600 .STOXX closed at a two-week high, up 1.2% on the day to complete a reversal of the losses posted during the global market turmoil in the first half of August.
All the major regional bourses, including those of Germany .GDAXI, France .FCHI, Italy .FTMIB and Spain .IBEX were also more than 1% higher.
U.S. retail sales rose more than expected in July, keeping investor bets on a smaller than 50-basis-point Federal Reserve interest rate cut intact.
"The numbers should lay to rest - at least for the moment - all of the doom and gloom that was expressed at the beginning of this month," said Chris Zaccarelli, chief investment officer for Independent Advisor Alliance.
"The Fed can begin a rate-cutting cycle without the economy entering recession, and history shows this is an extremely positive environment for the stock market."
Rate-sensitive technology shares .SX8P, among the hardest hit during the rout, were Thursday's biggest gainers, up 2.6% with semiconductor players such as ASML Holding ASML.AS and ASM International ASMI.AS leading the way.
The volatility "fear gauge" .V2TX retreated to its lowest level since late July.
Banks .SX7E, retail .SXRP and automobiles .SXAP were also among the top performers, although most sectors gained on the day.
Dutch payments company Adyen ADYEN.AS was the strongest individual performer, jumping 12% to top the STOXX 600 after market share gains helped it beat half-year core profit expectations.
British motor and home insurer Admiral ADML.L climbed 6.5% after posting a forecast-beating first-half profit.
AstraZeneca AZN.L rose nearly 2%, marking a record high for a fourth-straight session, after the U.S. Food and Drug Administration granted its blockbuster cancer drug Imfinzi a priority review for patients with limited-stage small cell lung cancer in the United States.
Renewable energy group Orsted ORSTED.CO was the day's worst Stoxx 600 performer, slumping 7.2% after booking 3.9 billion Danish crowns ($574.4 million) in impairment losses in second quarter.
Swedish games developer Embracer EMBRACb.ST fell more than 7% after a reporting a 50% drop in first-quarter operating profit, and Swiss plumbing materials supplier Geberit GEBN.S lost nearly 2% after disappointing with a forecast for 2024 organic sales similar to those of last year.
($1 = 6.7899 Danish crowns)
Reporting by Pranav Kashyap and Ankika Biswas in Bengaluru; Editing by Subhranshu Sahu and Janane Venkatraman
Aset Berkaitan
Berita Terkini
Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.
Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.
Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.
